Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Valeria StefanizziDepartment of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, I-98166 Messina, Italy.ORCID 0000-0003-0516-5683
Antonella MinutoloDepartment of Experimental Medicine, University of Rome "Tor Vergata", I-00133 Rome, Italy.ORCID 0000-0003-4784-4297
Evariste MolimbouDepartment of Experimental Medicine, University of Rome "Tor Vergata", I-00133 Rome, Italy.ORCID 0009-0004-8359-3178
Emanuela BalestrieriDepartment of Experimental Medicine, University of Rome "Tor Vergata", I-00133 Rome, Italy.
Martina GiudiceDepartment of Experimental Medicine, University of Rome "Tor Vergata", I-00133 Rome, Italy.
Franca M CorderoDepartment of Chemistry "Ugo Schiff", University of Florence, I-50019 Sesto Fiorentino, Italy.ORCID 0000-0001-6005-5941
Claudia MoscaDepartment of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, I-98166 Messina, Italy.ORCID 0009-0001-8457-4591
Antonio MastinoThe Institute of Translational Pharmacology, Consiglio Nazionale delle Ricerche, I-00133 Rome, Italy.ORCID 0000-0002-0338-6450
Beatrice MacchiDepartment of Chemical Science and Technology, University of Rome "Tor Vergata", I-00133 Rome, Italy.ORCID 0000-0003-0878-1799
Claudia MatteucciDepartment of Experimental Medicine, University of Rome "Tor Vergata", I-00133 Rome, Italy.ORCID 0000-0002-6058-1092
Sandro GrelliDepartment of Experimental Medicine, University of Rome "Tor Vergata", I-00133 Rome, Italy.ORCID 0000-0003-1028-3203
Francesca Marino-MerloDepartment of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, I-98166 Messina, Italy.ORCID 0000-0001-7898-583X
Funding
European Union - Next Generation PRIN2022 "Enforcing the THERapeutic Arsenal againsSt Emerging and Reemerging RNA Viruses" EU_2022W97H54_003-CUP J53D23001200006Italian Ministry of University and Research PRIN - Research Projects of National Relevance, no: 2017M8R7N9_002
6 · The paper itself
Abstract
Among the metal-derived complexes, recently, tin derivatives have been investigated as promising anti-cancer drug candidates. Our previous study showed that the tin-based compound Bu
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Cytotoxic Effects of a Triorganotin Derivative on HTLV-1-Infected Cells at Different Immortalization/Transformation Stages In Vitro. · full record | Socratic